RTX Corporation stock faces headwinds from Pratt & Whitney engine recalls and missile settlement amid record defense backlog

RTX Corporation stock (ISIN: US75511L1035) grapples with $1 billion missile liability and $2.8 billion in engine recall costs at Pratt & Whitney, offsetting robust F-35 orders and $202 billion defense backlog. US investors watch NYSE-listed shares for national security exposure and 2.9% yield resilience.

RTX Corporation stock has faced downward pressure on the NYSE amid fresh disclosures on a $1 billion missile settlement liability and ongoing Pratt & Whitney engine recalls costing $2.8 billion through 2026. These execution challenges in commercial aerospace contrast sharply with record defense bookings, including $12 billion in Q1 2026 orders for F-35 engines and hypersonic weapons. For US investors, the stock's role in Pentagon spending and Dividend Aristocrat status make it a key holding despite near-term margin squeezes.

As of: 25.03.2026

Elena Vasquez, Aerospace & Defense Market Editor: RTX Corporation stock navigates legacy engine issues against unbreakable US defense demand, positioning it as a core portfolio stabilizer in volatile geopolitics.

Recent Triggers: Missile Settlement and Engine Recalls Pressure Margins

RTX Corporation stock, listed on the NYSE under ISIN US75511L1035, pulled back modestly this week following a February 2026 disclosure of a $1 billion settlement tied to defective missiles in the US Army's PAC-3 program. Quality control lapses from 2024 audits triggered this liability, booked in Q4 2025 earnings and contributing to a 2% miss on adjusted EPS. Shares traded around $105 USD on the NYSE as of March 24, 2026 close, down 1.5% over the past week amid broader market shifts away from defensives.

Compounding the missile issue, Pratt & Whitney's recall of over 600 geared turbofan (GTF) engines used in commercial jets has escalated costs to $2.8 billion through 2026. Powder metal contamination in turbine disks forced airlines like Delta and United to ground fleets, hitting RTX's commercial aerospace segment, which generates 40% of its revenue. Management expects 80% of inspections complete by Q3 2026, with $1.4 billion in customer settlements to offset expenses.

These headwinds dominate short-term sentiment, but RTX's defense segments provide insulation. Q1 2026 brought $12 billion in new orders, underscoring demand for military hardware amid global tensions. Investors parse whether these costs signal deeper execution risks or temporary setbacks in a sector prized for long-cycle contracts.

Defense Backlog Hits Record $202 Billion on Geopolitical Demand

RTX's Collins Aerospace and Raytheon units drove funded backlog to $202 billion at 2025 year-end, equating to 3.5 years of revenue coverage. This surge stems from key wins like $4.5 billion for Patriot missile interceptors linked to Ukraine aid and $2.2 billion for SPY-6 radars on US Navy destroyers. Geopolitical tensions in Europe and the Middle East bolster these contracts, insulating RTX from commercial volatility.

Military engines, comprising 60% of Pratt & Whitney revenue, remain unaffected by recalls, supporting 156 annual F-35 deliveries ramping to 200 by 2028. Hypersonic programs and Next-Gen Air Dominance initiatives position RTX for $50 billion in potential future awards. On the NYSE, this backlog underpins RTX Corporation stock's appeal as a defense pure-play with predictable cash flows.

US national security priorities amplify relevance. The Pentagon's $850 billion budget request ensures tailwinds, with RTX capturing share in missiles, radars, and jets. Investors value this visibility, contrasting cyclical commercial aerospace risks.

Pratt & Whitney Recovery: Execution Risks in Commercial Aero

Pratt & Whitney's GTF troubles trace to manufacturing defects, prompting aggressive remediation. RTX plans full fleet inspections by late 2026, prioritizing high-cycle engines. Commercial margins, squeezed to low single digits, should recover as new production ramps with cleaner processes.

Yet risks persist. Airline pushback on costs could extend disputes, while supply chain delays hinder timelines. RTX's $2.7 billion annual R&D spend accelerates fixes, but any slippage impacts group profitability. Military stability—F-35 sole-source engines—offsets 40% commercial exposure.

For RTX Corporation stock on the NYSE, this divide highlights segment dynamics. Defense reliability tempers aero volatility, appealing to balanced portfolios. Q1 earnings on April 22 will test progress on cost absorption and backlog conversion.

US Investor Relevance: Dividend Aristocrat with Fiscal Tailwinds

RTX Corporation stock suits US investors seeking defense exposure with income. As a Dividend Aristocrat with 30+ years of raises, it yields 2.9% at recent NYSE levels around $105 USD, covered 1.8x by earnings. Low beta of 0.65 suits 401(k)s amid market rotations.

Bipartisan Washington consensus on defense spending transcends elections, with $850 billion FY2027 requests favoring RTX. R&D tax credits and IRA provisions enhance after-tax returns. At 19x 2026 EPS, valuation aligns with peers, balancing 8-10% revenue CAGR potential.

Scale advantages—$75 billion market cap—fund hypersonics and directed energy, areas of Pentagon priority. US portfolios benefit from RTX's entrenchment in Next-Gen programs, offering growth atop stability. Fiscal policy shifts amplify this edge for domestic holders.

Risks and Open Questions: Margin Expansion and Execution

Near-term risks center on Pratt & Whitney cost overruns exceeding $2.8 billion forecasts. Missile settlement appeals or commercial disputes could add charges. Broader supply chain strains in titanium and electronics test delivery schedules.

Geopolitical shifts pose upside risks but also execution hurdles. Ukraine aid volatility or Middle East escalations boost orders yet strain capacity. RTX targets 13.5% group margins by 2027, hinging on aero recovery and defense pricing power.

Valuation sensitivity looms at 19x; EPS misses could pressure NYSE shares toward 17x peer lows. Watch cash flow for dividend sustainability amid $1.4 billion settlements. Long-term, hypersonic ramps offer leverage, but Q1 updates prove pivotal.

Strategic Outlook: RTX's Position in Evolving Defense Landscape

RTX Corporation stock embodies aerospace-defense convergence. Record backlog shields cyclicality, while commercial fixes pave margin rebound. US investors prioritize this moat in national security-critical tech.

Production ramps—F-35 to 200 units, Patriot expansions—drive revenue. R&D leadership in hypersonics positions RTX for multi-decade cycles. NYSE trading reflects balanced risk-reward for patient capital.

Overall, headwinds test resilience, but structural demand endures. US portfolios gain from RTX's scale and policy alignment.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.